V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004402 | 310009173 | 1.92 | null | Palliative (P) | 2016-09-16 | 2016-10-16 | GEM-P | 02 | null | 310019777 | RITUXIMAB |
| 310004403 | 310009173 | 1.83 | 80 | null | null | 2014-12-07 | CHOEP - 14 days | N | N | 310019777 | CHOEP |
| 310004404 | 310009173 | 1.65 | 75 | Palliative (P) | 2014-04-24 | 2014-04-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310019777 | EOX |
| 310004405 | 310001921 | 1.83 | 87.6 | Curative (C) | 2017-10-31 | 2017-10-31 | null | N | N | 310019784 | NOT MATCHED |
| 310004406 | 310001922 | 1.55 | 56.3 | Disease modification (D) | 2015-03-26 | 2015-03-26 | Bevacizumab+Carbo+Pacliaxel | null | null | 310019788 | VEMURAFENIB |
| 310004407 | 310001922 | 1.68 | 54 | Disease modification (D) | 2012-09-28 | 2013-04-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 310019788 | ICON TRIAL |
| 310004408 | 310001923 | 0 | null | Palliative (P) | 2015-04-20 | 2015-04-30 | Liposomal Doxorubicin (Caelyx) | N | N | 310019790 | CAPECITABINE + OXALIPLATIN |
| 310004410 | 310001925 | 1.55 | 53.1 | Curative (C) | 2017-06-10 | 2017-06-15 | CHOEP - 14 days | null | null | 310019799 | CHOEP |
| 310004411 | 310001926 | 6.8 | 90.3 | Neo-adjuvant (N) | 2013-05-09 | 2013-05-27 | ECX | N | N | 310019801 | ECX |
| 310004412 | 310006824 | 1.7 | 114.8 | Neo-adjuvant (N) | 2017-11-15 | 2017-11-16 | CHOEP - 21 days | 02 | N | 310019802 | HYDROXYCARBAMIDE |
| 310004413 | 310006824 | 1.83 | null | Curative (C) | 2017-02-03 | 2017-02-04 | NB HRNBL-1 MOD N7 CAV | N | N | 310019802 | NOT MATCHED |
| 310004414 | 310001927 | 0 | 72.5 | Curative (C) | 2017-07-30 | 2017-08-03 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | N | N | 310019812 | NOT MATCHED |
| 310004415 | 310001928 | 1.53 | 0 | Curative (C) | 2016-12-26 | 2017-01-15 | CHOEP - 21 days | N | N | 310019813 | CHOEP |
| 310004416 | 310001928 | 0 | 69.2 | Disease modification (D) | 2015-07-06 | 2015-07-07 | Liposomal Doxorubicin (Caelyx) | 2 | N | 310019813 | VEMURAFENIB |
| 310004417 | 310001928 | 0 | 64 | Palliative (P) | 2015-01-03 | 2015-01-24 | ECX | null | N | 310019813 | ECX |
| 310004418 | 310001928 | 1.68 | 45 | null | null | 2014-10-08 | CHOEP - 14 days | 02 | N | 310019813 | CHOEP |
| 310004419 | 310001928 | null | 59.9 | Curative (C) | 2016-09-09 | 2016-09-10 | ALL Int Guide B Ind Ph 1 PegAsp | N | N | 310019813 | NOT MATCHED |
| 310004420 | 310001929 | 1.79 | 0 | null | null | 2015-07-30 | EOX | 2 | N | 310019823 | EOX |
| 310004421 | 310001930 | 1.61 | 59 | Curative (C) | 2015-12-05 | 2015-12-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310019824 | CAPECITABINE + CISPLATIN |
| 310004422 | 310001930 | 1.61 | 73 | Palliative (P) | 2017-12-08 | 2017-12-08 | Cisplatin +Fluorouracil (3 wk) | N | N | 310019824 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004423 | 310009176 | 1.56 | 66 | Neo-adjuvant (N) | 2016-09-02 | 2016-09-20 | Hydroxycarbamide | 02 | N | 310019827 | HYDROXYCARBAMIDE |
| 310004424 | 310001931 | 1.53 | 63.5 | Palliative (P) | 2013-08-27 | 2013-09-14 | EOX | 2 | N | 310019828 | VEMURAFENIB |
| 310004425 | 310001932 | null | 74.7 | Disease modification (D) | 2015-09-24 | 2016-04-11 | EOX | 2 | N | 310019829 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004426 | 310001932 | 1.59 | 70.2 | Palliative (P) | 2018-01-29 | 2018-01-29 | CISPLATIN + FLUOROURACIL | N | N | 310019829 | DACARBAZINE |
| 310004427 | 310001932 | null | null | Neo-adjuvant (N) | 2013-09-09 | 2013-09-28 | Dacarbazine | N | N | 310019829 | VEMURAFENIB |
| 310004428 | 310001933 | 1.58 | 43.6 | Palliative (P) | 2015-09-27 | 2015-10-11 | Liposomal Doxorubicin (Caelyx) | N | N | 310019834 | PACLITAXEL |
| 310004429 | 310001934 | 1.61 | 50 | Palliative (P) | 2017-10-07 | 2017-10-11 | Dacarbazine | N | null | 310019835 | DACARBAZINE |
| 310004430 | 310001934 | 1.61 | 45.7 | Adjuvant (A) | 2016-05-12 | 2016-05-14 | Oxaliplatin + Modified de Gramont | N | Y | 310019835 | EOX |
| 310004431 | 310001934 | null | 110.4 | Adjuvant (A) | 2014-08-15 | 2014-09-05 | BCG Intravesical | N | N | 310019835 | CISPLATIN + ETOPOSIDE |
| 310004432 | 310010407 | 1.76 | 54.8 | Palliative (P) | 2014-01-03 | 2014-01-03 | CISPLATIN + FLUOROURACIL | 02 | N | 310019842 | DACARBAZINE |
| 310004433 | 310011082 | 1.6 | 80.2 | Palliative (P) | 2016-05-04 | 2016-05-14 | Imatinib 400mg | Y | N | 310019843 | PACLITAXEL |
| 310004434 | 310011082 | 1.76 | 57 | Palliative (P) | 2015-09-03 | 2015-09-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 310019843 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004435 | 310001935 | 1.67 | 82 | Disease modification (D) | 2013-09-25 | 2013-09-26 | Bexarotene | 02 | N | 310019847 | BCG |
| 310004436 | 310001936 | null | 97.4 | null | 2015-02-11 | 2015-02-22 | CHOEP - 21 days | N | N | 310019849 | CHOEP |
| 310004437 | 310001937 | null | 72.15 | Palliative (P) | 2016-07-08 | 2016-07-22 | Vemurafenib | 02 | N | 310019851 | OXALIPLATIN + MDG |
| 310004438 | 310001938 | 1.59 | 67 | Curative (C) | 2014-02-06 | 2014-02-06 | CNS Pineoblastoma guidelines VVV/Etop/Carbo | 02 | N | 310019855 | NOT MATCHED |
| 310004439 | 310001939 | 1.7 | 0 | Neo-adjuvant (N) | 2013-07-23 | 2013-08-13 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310019856 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004440 | 310001940 | 1.61 | 59 | Palliative (P) | 2013-10-17 | 2013-10-17 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 310019858 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004441 | 310006829 | 1.73 | 79.7 | Curative (C) | 2018-02-18 | 2018-02-18 | Paclitaxel 7 day | N | N | 310019860 | CISPLATIN + ETOPOSIDE |
| 310004442 | 310006829 | null | null | Palliative (P) | 2015-01-22 | 2015-02-04 | CISPLATIN + FLUOROURACIL | Y | null | 310019860 | CAPECITABINE + CISPLATIN |
| 310004443 | 310001941 | 1.7 | 68.7 | Curative (C) | 2018-07-20 | 2018-07-25 | Capecitabine + Cisplatin | N | null | 310019863 | CAPECITABINE + OXALIPLATIN |
| 310004444 | 310001942 | null | 100.3 | Palliative (P) | null | 2016-05-23 | ECX | N | N | 310019864 | ECX |
| 310004445 | 310006830 | null | 71.1 | null | 2017-07-19 | 2017-07-20 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 310019865 | GEMCITABINE |
| 310004446 | 310009180 | 0 | 62 | Palliative (P) | 2016-08-21 | 2016-08-21 | Capecitabine + Oxaliplatin 21day | N | N | 310019866 | CAPECITABINE + OXALIPLATIN |
| 310004447 | 310001943 | 1.81 | null | Palliative (P) | 2017-12-15 | 2017-12-16 | Oxaliplatin + Modified de Gramont | N | N | 310019868 | CISPLATIN + ETOPOSIDE |
| 310004448 | 310006831 | 1.76 | 80.2 | Curative (C) | 2017-11-06 | 2017-11-05 | Retinoblastoma Rel IA Melphalan | 02 | N | 310019870 | NOT MATCHED |
| 310004449 | 310006831 | 1.86 | 81.5 | Palliative (P) | 2013-10-20 | 2013-10-22 | Capecitabine + Cisplatin | null | null | 310019870 | RITUXIMAB |
| 310004450 | 310010408 | 1.74 | null | Palliative (P) | 2013-05-09 | 2013-05-20 | IPILIMUMAB + NIVOLUMAB | null | null | 310019874 | IPILIMUMAB + NIVOLUMAB |
| 310004451 | 310001944 | 1.75 | 66.9 | Neo-adjuvant (N) | 2013-11-03 | 2013-11-08 | Dacarbazine | 02 | N | 310019875 | HYDROXYCARBAMIDE |
| 310004452 | 310001945 | null | 75 | Adjuvant (A) | 2017-01-25 | 2017-03-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310019878 | ICON TRIAL |